Felid herpesvirus 1 (ATCC® VR-1787)

Classification: Herpesviridae, Varicellovirus  /  Product Format: frozen 1 mL per vial

Permits and Restrictions

View Permits

Classification Herpesviridae, Varicellovirus
Deposited As Feline rhinotracheitis virus
Agent Felid herpesvirus 1
Strain FVRm (modified)
Biosafety Level 2
Product Format frozen 1 mL per vial
Storage Conditions -70°C or colder
Images ATCC VR-1787 images
Comments Derived by adaptation from primary cell culture product ATCC® VR-815™ to CRFK cells (ATCC® CCL-94™).  ATCC® VR-815™ and ATCC® VR-1787™ have not been compared for sequence or infectivity in primary cell culture and tissue culture. Item is a vaccine strain. Antigenicity is specific for virus.
Effect on Host
CPE, cell rounding and sloughing
Recommended Host
CRFK (ATCC® CCL-94™)
Growth Conditions Temperature: 31°C
Recommendations for Infection: Plate cells 24-48 hours prior to infection and infect when cultures are 80-90% confluent. Remove medium and inoculate with a small volume of virus (e.g. 1 mL per 25 cm2) diluted to provide an optimal MOI (e.g. 0.01). Adsorb 1-2 hours at 31°C in a humidified 5% CO2 atmosphere, rocking every 10-15 minutes to redistribute inoculum. End adsorption by adding virus growth medium.
Incubation: 3-5 days
Effect on Host
CPE, cell rounding and sloughing
Name of Depositor EV Davis, Norden Laboratories, Inc.
Source Throat swab from a 3 month old cat
References

Davis E. Feline viral rhinotracheitis vaccine and combination feline viral rhinotracheitis-calicivirus vaccine prepared therefrom. US Patent 4,031,204 dated Jun 21 1977

Notice: Necessary PermitsPermits

These permits may be required for shipping this product:

  • Customers located in the state of Hawaii will need to contact the Hawaii Department of Agriculture to determine if an Import Permit is required. A copy of the permit or documentation that a permit is not required must be sent to ATCC in advance of shipment.
Basic Documentation
Other Documentation